Cumberland Pharmaceuticals (CPIX) Return on Capital Employed (2011 - 2026)

Cumberland Pharmaceuticals has disclosed Return on Capital Employed across 16 years of filings, most recently posting 18.3% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 18.3%, down 1137.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.3% (down 1137.0% YoY), and the FY2025 annual result was 7.08%, up 659.0% from the prior year.
• Return on Capital Employed came in at 18.3% for Q1 2026 at Cumberland Pharmaceuticals, down from 8.07% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6.52% in Q2 2023 to a low of 23.14% in Q3 2024.
• The 5-year median for Return on Capital Employed is 11.73% (2022), against an average of 12.43%.
• Across the five-year window, Return on Capital Employed tumbled 1391 bps in 2024 and jumped 1548 bps in 2025, its largest moves.
• Cumberland Pharmaceuticals' Return on Capital Employed stood at 9.02% in 2022, then sank by 87 bps to 16.83% in 2023, then gained by 14 bps to 14.44% in 2024, then soared by 44 bps to 8.07% in 2025, then plunged by 127 bps to 18.3% in 2026.
• The last three Return on Capital Employed figures came in at 18.3% (Q1 2026), 8.07% (Q4 2025), and 7.66% (Q3 2025), per Business Quant data.